Cargando…
Long non-coding RNA HEIH: a novel tumor activator in multiple cancers
The last decade has witnessed the altered expression levels of long non-coding RNA HEIH in different types of cancer. More than half of the HEIH studies in cancer have been published within the last two years. To our knowledge, this is the first review to discuss very recent developments and insight...
Autores principales: | Sun, Jie-yu, Ni, Ming-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543845/ https://www.ncbi.nlm.nih.gov/pubmed/34689775 http://dx.doi.org/10.1186/s12935-021-02272-5 |
Ejemplares similares
-
Long non‐coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma
por: Ding, XinYu, et al.
Publicado: (2020) -
LncRNA HEIH expression in cancer prognosis: A review and meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2023) -
Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression
por: Xu, Haili, et al.
Publicado: (2021) -
The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018) -
High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis
por: He, Chaowen, et al.
Publicado: (2022)